You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Colorcon
Boehringer Ingelheim
Medtronic
Johnson and Johnson

Last Updated: March 29, 2020

DrugPatentWatch Database Preview

Details for Patent: 4,743,450


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,743,450
Title: Stabilized compositions
Abstract:The cyclization, hydrolysis, and coloration of certain ACE inhibitors is minimized when they are formulated with a metal-containing stabilizer and a saccharide.
Inventor(s): Harris; Michael (Hackettstown, NJ), Hokanson; Gerard (Long Valley, NJ), Murthy; Kuchi (Morris Plains, NJ), Reisch; Robert (Haledon, NJ), Waldman; Frank (Wayne, NJ)
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Application Number:07/017,962
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,743,450
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Formulation; Process;

Drugs Protected by US Patent 4,743,450

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,743,450

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 84210   Start Trial
Australia 1130588   Start Trial
Australia 597471   Start Trial
Canada 1300510   Start Trial
Germany 3877226   Start Trial
Denmark 169593   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Boehringer Ingelheim
Express Scripts
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.